This content is machine translated Melanoma in advanced stages Treatment strategies in the adjuvant and neoadjuvant setting The introduction of checkpoint inhibitors and targeted therapy with kinase inhibitors revolutionized the treatment options for patients with advanced-stage melanoma. While there is already a lot of evidence for immunotherapy…
View Post 4 min This content is machine translated 28th German Skin Cancer Congress 2018, Stuttgart Update on immunotherapy of malignant melanoma Combination immunotherapy, adjuvant immune checkpoint blockade, and long-term survival after PD-1 inhibitor therapy were the topics of two satellite symposia at the German Skin Cancer Congress.
View Post 6 min This content is machine translated ESMO 2017 in Madrid Blocking the “escape route” for the tumor Upsets in first-line therapy of non-small cell EGFR-mutated lung cancer are imminent. With the FLAURA trial, osimertinib is confidently presenting itself for the first time as a treatment option for…
View Post 9 min This content is machine translated Radiation-associated angiosarcoma of the breast What can we learn from case reports? Radiation-associated angiosarcoma is more common than intuitively expected. The initial diagnosis should be made as early as possible. Paradoxically, even in this radiation-induced tumor, re-irradiation is a good therapeutic option.
View Post 10 min This content is machine translated Treatment of epithelial ovarian cancer. Slow but steady progress Epithelial ovarian carcinoma is a heterogeneous group of carcinomas that have different etiology, genetics, and thus biological prognosis. In advanced stages (IIB-IV), the standard therapy remains maximal cytoreductive therapy, weighing…
View Post 7 min This content is machine translated HER2-positive breast carcinoma New substances enable targeted therapy The HER2 receptor belongs to the family of four transmembrane receptor tyrosine kinases (EGFR/HER1, HER2, HER3, and HER4) that influence cell growth, differentiation, and survival. Overexpression of HER2 occurs in…